Decorin‐mediated oncosuppression – a potential future adjuvant therapy for human epithelial cancers
Open Access
- 27 February 2018
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 176 (1) , 5-15
Abstract
Currently, the multifaceted role of the extracellular matrix (ECM) in tumourigenesis has been realized. One ECM macromolecule exhibiting potent oncosuppressive actions in tumourigenesis is decorin, the prototype of the small leucine‐rich proteoglycan gene family. The actions of decorin include its ability to function as an endogenous pan‐receptor tyrosine kinase inhibitor, a regulator of both autophagy and mitophagy, as well as a modulator of the immune system. In this review, we will discuss these topics in more detail. We also provide a summary of preclinical studies exploring the value of decorin‐mediated oncosuppression, as a potential future adjuvant therapy for epithelial cancers.Linked Articles: This article is part of a themed section on Translating the Matrix. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.1/issuetocKeywords
Funding Information
- Lounais-Suomen Syöpäyhdistys
This publication has 62 references indexed in Scilit:
- THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptorsBritish Journal of Pharmacology, 2017
- Decorin: A Growth Factor Antagonist for Tumor Growth InhibitionBioMed Research International, 2015
- Proteoglycan–LDL interactions: A novel therapeutic target?Atherosclerosis, 2014
- FOXD1 promotes nephron progenitor differentiation by repressing decorin in the embryonic kidneyDevelopment, 2014
- Decorin Mimic Inhibits Vascular Smooth Muscle Proliferation and MigrationPLOS ONE, 2013
- Biological interplay between proteoglycans and their innate immune receptors in inflammationThe FEBS Journal, 2013
- Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in miceCarcinogenesis, 2011
- Decorin Protein Core Inhibits in Vivo Cancer Growth and Metabolism by Hindering Epidermal Growth Factor Receptor Function and Triggering Apoptosis via Caspase-3 ActivationJournal of Biological Chemistry, 2006
- Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinomaThe International Journal of Biochemistry & Cell Biology, 2003
- Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002